跳至主要内容
临床试验/NCT03790371
NCT03790371已完成3 期

Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion Following Previous Insertion Failure

Ain Shams University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2015年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
90
试验地点
1
主要终点
the success rate for IUD insertion.

研究概览

简要总结

the current study was conducted to assess efficacy of vaginal misoprostol before IUD insertion following previous insertion failure

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • One previous failed attempt of IUD insertion.

排除标准

  • Uterine fibroid distorting the cavity.
  • Anatomical uterine abnormality with distortion of the cavity
  • Current pelvic inflammatory disease or recently treated pelvic inflammatory disease (PID) in the last three months.
  • Current purulent cervicitis (chlamydia or gonorrhea).
  • Immediately after septic abortion.
  • Uterus size less than 6 cm and more than 9 cm.

研究组 & 干预措施

misoprostol group

Active Comparator

misoprostol (misotac® sigma pharmaceutical industries) 200 mcg vaginally applied ten and four hours prior to the second attempt of IUD insertion

干预措施: Misoprostol (Drug)

placebo

Placebo Comparator

while the control group received a placebo tablet in the same regimen as the study group.

干预措施: Placebos (Drug)

结局指标

主要结局

the success rate for IUD insertion.

时间窗: four hours after misoprostol dose

the success of IUD insertion after previous attempt failure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Radwa Rasheedy Ali

Principal Investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验